Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
PurposeCancer-related insomnia is associated with diminished quality of life (QOL), suggesting that improvement in insomnia may improve QOL in cancer survivors. Cognitive behavioral therapy for insomnia (CBT-I) has been shown to improve insomnia, but less is known regarding its effect on QOL and whether improvement in insomnia corresponds to improved QOL. The present analysis examines the effects of CBT-I, with and without armodafinil, on QOL both directly and indirectly through improvements of insomnia.MethodsThis is an analysis of 95 cancer survivors for a specified secondary aim of a four-arm randomized controlled trial assessing the combined and individual effects of CBT-I and armodafinil to improve insomnia. QOL and insomnia severity were assessed before, during the intervention, at post-intervention, and 3 months later by Functional Assessment of Cancer Therapy—General and Insomnia Severity Index, respectively.ResultsMean change in QOL from pre- to post-intervention for CBT-I + placebo, CBT-I + armodafinil, armodafinil, and placebo was 9.6 (SE = 1.8; p < 0.0001), 11.6 (SE = 1.8; p < 0.0001), −0.2 (SE = 3.2; p = 0.964), and 3.3 (SE = 2.0; p = 0.124), respectively. ANCOVA controlling for pre-intervention scores showed that participants receiving CBT-I had significantly improved QOL at post-intervention compared to those not receiving CBT-I (p < 0.0001, effect size = 0.57), with benefits being maintained at the 3-month follow-up. Path analysis revealed that this improvement in QOL was due to improvement in insomnia severity (p = 0.002), and Pearson correlations showed that changes in QOL from pre- to post-intervention were significantly associated with concurrent changes in insomnia severity (r = −0.56; p < 0.0001). Armodafinil had no effect on QOL for those who did or did not receive it (p = 0.976; effect size = −0.004).ConclusionIn cancer survivors with insomnia, CBT-I resulted in clinically significant improvement in QOL via improvement in insomnia. This improvement in QOL remained stable even 3 months after completing CBT-I.Implications for Cancer SurvivorsConsidering the high prevalence of insomnia and its detrimental impact on QOL in cancer survivors and the effectiveness of CBT-I in alleviating insomnia, it is important that evidence-based non-pharmacological sleep interventions such as CBT-I be provided as an integral part of cancer care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Institutes of Health State of the Science Conference Statement
(2005) · Sleep · doi:10.1093/sleep/28.9.1049 · Cited by 745
Sleep disturbance in cancer patients
Davidson, J. R., MacLean, A. W., Brundage, M. D., & Schulze, K. (2002) · Social Science & Medicine · doi:10.1016/s0277-9536(01)00043-0 · Cited by 661
Brucker, P. S., Yost, K., Cashy, J., Webster, K., & Cella, D. (2005) · Evaluation & the Health Professions · doi:10.1177/0163278705275341 · Cited by 528
Savard, M.-H., Savard, J., Simard, S., & Ivers, H. (2005) · Psycho-Oncology · doi:10.1002/pon.860 · Cited by 449
Self-citationPrevalence, Clinical Characteristics, and Risk Factors for Insomnia in the Context of Breast Cancer
Savard, J., Simard, S., Blanchet, J., Ivers, H., & Morin, C. M. (2001) · SLEEP · doi:10.1093/sleep/24.5.583 · Cited by 414
Espie, C. A., Fleming, L., Cassidy, J., Samuel, L., Taylor, L. M., White, C. A., Douglas, N. J., Engleman, H. M., Kelly, H.-L., & Paul, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9006 · Cited by 383
Johnson, J. A., Rash, J. A., Campbell, T. S., Savard, J., Gehrman, P. R., Perlis, M., Carlson, L. E., & Garland, S. N. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.07.001 · Cited by 371
Self-citationGarland, S. N., Carlson, L. E., Stephens, A. J., Antle, M. C., Samuels, C., & Campbell, T. S. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.7265 · Cited by 329
Self-citationRitterband, L. M., Bailey, E. T., Thorndike, F. P., Lord, H. R., Farrell‐Carnahan, L., & Baum, L. D. (2012) · Psycho-Oncology · doi:10.1002/pon.1969 · Cited by 296
Campbell, T., Garland, S., Johnson, J., Savard, J., Gehrman, P., Perlis, M., & Carlson, L. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s47790 · Cited by 250
Self-citation
Cited by
Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., Cape, J., Ong, J. C., Sheaves, B., Foster, R., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2745 · Cited by 466
Perlis, M. L., Posner, D., Riemann, D., Bastien, C. H., Teel, J., & Thase, M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00879-0 · Cited by 395
Self-citationSleep Disorders in Cancer—A Systematic Review
Büttner-Teleagă, A., Kim, Y.-T., Osel, T., & Richter, K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111696 · Cited by 186
“, Journal of Cancer Survivorship 2017; 11 (3): 401–409 [55] 95 Cancer patients with Insomnia Insomnia Severity Index (ISI); FACT-G (QoL) (Functional Assessment of Cancer Therapy - General) T1—Baseline T2—Post-Treatment (7 weeks) T3—Follow-up (3 months) v No sleep results !!! v CBT-I + A & CBT-I + P:”
BackgroundEfficacy of cognitive behavioral therapy for insomnia in breast cancer: A meta-analysis
Ma, Y., Hall, D. L., Ngo, L. H., Liu, Q., Bain, P. A., & Yeh, G. Y. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101376 · Cited by 151
Hulbert-Williams, N. J., Beatty, L., & Dhillon, H. M. (2018) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0000000000000360 · Cited by 88
Metadata
- Authors
- Peoples, A. R., Garland, S. N., Perlis, M. L., Savard, J., Heckler, C. E., Kamen, C. S., Ryan, J. L., Mustian, K. M., Janelsins, M. C., Peppone, L. J., Morrow, G. R., & Roscoe, J. A.
- Venue
- Journal of Cancer Survivorship
- Published
- 2017-01-19
- Volume
- 11
- Issue
- 3
- Pages
- 401-409
- ISSN
- 1932-2259 (ISSN-L)
- 1932-2267
- OpenAlex
- W2573797667
- Cited by
- 33
- References
- 16
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial. https://app.cochat.ai/papers/10.1007/s11764-017-0597-0
- The paper
- Peoples, A. R., Garland, S. N., Perlis, M. L., Savard, J., Heckler, C. E., Kamen, C. S., Ryan, J. L., Mustian, K. M., Janelsins, M. C., Peppone, L. J., Morrow, G. R., & Roscoe, J. A. (2017). Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-017-0597-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.